Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Curacen
- Development stage
- Unknown
- Lead developer
- Japan Bio Products
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Administration
- Subcutaneous, Intramuscular, Topical, Oral
01
Overview
Curacen is a cosmetic and aesthetic biologic product developed by Japan Bio Products (JBP). It is composed of human placenta extract (hydrolyzate), which contains a rich array of bioactive substances including cell growth factors (such as EGF, FGF, CSF, IGF, NGF, and TGF-beta), interleukins, amino acids, vitamins, peptides, and minerals. The product is designed to promote skin rejuvenation, reduce wrinkles, and improve skin texture and tone by stimulating the production of collagen and elastin and enhancing cellular regeneration. Curacen is available in multiple formulations, including an injectable for mesotherapy, a topical essence, and oral capsules. It is manufactured using high-purification technology to ensure safety and bioavailability, leveraging the same pharmaceutical expertise used for the liver function drug Laennec.
- Brand names
- CuracenCuracen EssenceCuracen P.O.+
- Other names
- human placenta extracthuman placenta hydrolyzate
02
Targets
EGFR (Epidermal growth factor receptor)FGFR (FGFR family)IGF-1R (Insulin-like growth factor 1 receptor)TGFBR1/2 (Transforming growth factor-beta receptor type 1 and Transforming growth factor-beta receptor type 2)CSFR (Colony-stimulating factor receptor)NGFR (p75NTR)TGFBR (TGF-beta receptor)
Beyond the preview
Go deeper on Curacen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Curacen.